核酸适体(aptamer):一种具有潜力的肿瘤药物'靶向配基'

摘要

核酸适体(aptamer)可描述为化学抗体,是用配体指数富集法系统进化(SELEX)技术筛选获得的单链DNA或RNA,借其自身形成的空间结构与靶标分子特异性识别,具有靶分子广、亲和力高、特异性强、易改造修饰等特点.本文简述核酸适体作为肿瘤药物"靶向配基"的应用研究.%The aptamer is described as chemical antibody- It is single DNA. or RNA. that can be isolated against by an iterative in vi1.ro process called systematic evolution of ligands by exponential enrichment (SELEX) and can identify target molecules specificity through its own space structure. They possess the molecular recognition properties in terms of their high affinity, strong specificity and easy modified. This paper describes the aptamer application research as an antitumor drug ''targeted ligands''.